Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: Implications for the role of serotonin in the mechanism of antidepressant action

Biological Psychiatry

Volumn 46, Issue 2, 1999, Pages 212-220

  Delgado, Pedro L ^b   Miller, Helen L ^a,b   Salomon, Ronald M ^a,b   Licinio, Julio ^a,b   Krystal, John H ^a,b   Moreno, Francisco A ^a,b   Heninger, George R ^a,b   Charney, Dennis S ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Major depression; Monoamines; Norepinephrine

Indexed keywords

AMINO ACID MIXTURE; DESIPRAMINE; FLUOXETINE; NORADRENALIN; SEROTONIN; TRYPTOPHAN;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELAPSE; SEROTONINERGIC SYSTEM;

ADULT; AGED; AMINO ACIDS; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BRAIN; DEPRESSIVE DISORDER, MAJOR; DESIPRAMINE; FEMALE; FLUOXETINE; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; RECURRENCE; SEROTONIN; TIME FACTORS; TRYPTOPHAN;

EID: 0033032825     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00014-1     Document Type: Article

References (48)

1. Diagnostic and Statistical Manual of Mental Disorders. 3rd Ed, revised. 1987;American Psychiatric Association, Washington, DC.
2. Anderson G.M., Young J.G., Cohen D.J., Schlicht K.R., Patel N. Liquid-chromatographic determination of serotonin and tryptophan in whole blood and plasma. Clin Chem. 27:1981;775-776.
3. Benkelfat C., Seletti B., Palmour R.M., Hillel J., Ellenbogen M., Young S.N. Tryptophan depletion in stable lithium-treated patients with bipolar disorder in remission. Arch Gen Psychiatry. 52:1995;154-155.
4. Berman RM, Delgado PL, Miller HL, Price LH, Heninger GR, Charney DS. Correlates of depressive relapse in medicated depressed subjects undergoing acute tryptophan depletion. Presented at the 26th Annual Meeting of the Society for Neuroscience, Washington, DC, November, 1996.
5. Blier P., de Montigny C. Current advances in the treatment of depression. TIPS. 15:1994;220-226.
6. Blier P., de Montigny C. A role for the serotonin system in the mechanism of action of antidepressant treatments Preclinical evidence . J Clin Psychiatry. 51:(suppl 4):1990;14-20.
7. Bunney W.E. Jr, Davis J.M. Norepinephrine in depressive reactions A review . Arch Gen Psychiatry. 13:1965;483-494.
8. Carpenter LL, Anderson G, McDougle CJ, Kirwin PD, Price LH, Heninger GR (1997): Tryptophan depletion during continuous CSF sampling via indwelling lumbar catheter in healthy human subjects. Presented at the 150th Annual Meeting of the American Psychiatric Association, NR #72, San Diego, CA, May 19, 1997.
9. Eosinophilia-myalgia syndrome and L-tryptophan containing products - New Mexico, Minnesota, Oregon, and New York. MMWR. 38:1989;785-788.
10. Coppen A. The biochemistry of affective disorders. Br J Psychiatry. 113:1967;1237-1264.
11. Curzon G. Influence of plasma tryptophan on brain 5HT synthesis and serotonergic activity. Haber B., Gabay S. Serotonin Current Aspects of Neurochemistry and Function . 1981;207-219 Plenum Press, New York.
12. Curzon G. Relationships between plasma, CSF and brain tryptophan. J Neural Transm. 15:(suppl 15):1979;93-105.
13. Delgado P.L., Charney D.S. Neuroendocrine challenge studies in affective disorders. Horton R.W., Katona C. Biological Aspects of Affective Disorders. 1991;146-190 Academic Press, London.
14. Delgado P.L., Charney D.S., Price L.H., Aghajanian G.K., Landis H., Heninger G.R. Serotonin function and the mechanism of antidepressant action Reversal of antidepressant induced remission by rapid depletion of plasma tryptophan . Arch Gen Psychiatry. 47:1990;411-418.
15. Delgado P.L., Charney D.S., Price L.H., Landis H., Heninger G.R. Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects. Life Sci. 45:1989;2323-2332.
16. Delgado P.L., Miller H.M., Salomon R.M., Licinio J., Gelenberg A.J., Charney D.S. Monoamines and the mechanism of antidepressant action Effects of catecholamine depletion on mood in patients treated with antidepressants . Psychopharmacol Bull. 29:1993;389-396.
17. Delgado P.L., Moreno F.A., Potter R., Gelenberg A.J. Norepinephrine and serotonin in antidepressant action Evidence from neurotransmitter depletion studies . Briley M. Antidepressant Therapy at the Dawn of the Third Millennium. 1997;141-163 Martin Dunitz LTD, London.
18. Delgado PL, Moreno FA, Gelenberg AJ, Potter R (1997): Sequential catecholamine and 5-HT depletion in mirtazapine-treated depressives. Presented at the 36th Annual Meeting of the American College of Neuropsychopharmacology, Waikoloa, HI, December 8, 1997.
19. Delgado P.L., Price L.H., Heninger G.R., Charney D.S. Neurochemistry of affective disorders. Paykel E.S. Handbook of Affective Disorders. 2nd ed. 1992;Churchill Livingstone, London.
20. Delgado P.L., Price L.H., Miller H.L., et al. Rapid serotonin depletion as a provocative challenge test for patients with major depression Relevance to antidepressant action and the neurobiology of depression . Psychopharmacol Bull. 27:1991;321-330.
21. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch Gen Psychiatry. 54:1997;597-606.
22. Fernstrom J.D. Effects of the diet on brain neurotransmitters. Metabolism. 26:1977;207-223.
23. Haddjeri N., Blier P., de Montigny C. Noradrenergic modulation of central serotonergic neurotransmission acute and long-term actions of mirtazapine . Int Clin Psychopharmacol. 10:1995;11-17.
24. Harper A.E., Benevenga N.J., Wohlhueter R.M. Effects of ingestion of disproportionate amounts of amino acids. Physiol Rev. 50:1970;428-548.
25. Heslop K., Portas C.M., Curzon G. Effect of altered tryptophan availability on tissue and extracellular serotonin in the rat. Rollema J., Westerink B., Drijshout W.J. Monitoring Molecules in Neuroscience. 1991;259-261 Krits Repro, Meppel, Netherlands.
26. Hyman S.E., Nestler E.J. Initiation and adaptation A paradigm for understanding psychotropic drug action . Am J Psychiatry. 153:1996;151-162.
27. Lam R.W., Zis A.P., Grewal A., Delgado P.L., Charney D.S., Krystal J.H. Effects of acute tryptophan depletion in seasonal affective disorder in remission with light therapy. Arch Gen Psychiatry. 53:1995;41-44.
28. Lapin I.P., Oxenkrug G.F. Intensification of the central serotonergic processes as a possible determinant of the thymoleptic effect. Lancet. 1:1969;132-136.
29. Mazure C.M., Nelson J.C., Price L.H. Reliability and validity of the symptoms of major depressive illness. Arch Gen Psychiatry. 43:1986;451-456.
30. Miller H.L., Delgado P.L., Salomon R.M., et al. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression. Arch Gen Psychiatry. 53:1996;117-128.
31. Moja E.A., Cipollo P., Castoldi D., Tofanetti O. Dose-response decrease in plasma tryptophan and in brain tryptophan and serotonin after tryptophan-free amino acid mixtures in rats. Life Sci. 44:1989;971-976.
32. Moreno FA, McGavin C, Malan P, et al (1997): CSF monoamine metabolites during tryptophan depletion. Presented at the 36th Annual Meeting of the American College of Neuropsychopharmacology, Waikoloa, HI, December 10, 1997.
33. Murphy D.L., Cambell I., Costa J.L. Current status of the indoleamine hypothesis of the affective disorders. Lipton M.A., DiMascio A., Killam K.F. Psychopharmacology A Generation of Progress . 1978;1235-1247 Raven Press, New York.
34. Neumeister A., Praschak-Rieder N., Hebetaelmann B., Rao M.-L. Effects of tryptophan depletion on drug-free patients with seasonal affective disorder during a stable response to bright light therapy. Arch Gen Psychiatry. 54:1997;133-138.
35. Nishizawa S., Benkelfat C., Young S.N., et al. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A. 94:1997;5308-5313.
36. Price L.H., Charney D.S., Delgado P.L., Heninger G.R. Effects of desipramine and fluvoxamine treatment on the prolactin response to L-tryptophan A test of the serotonergic function enhancement hypothesis of depression . Arch Gen Psychiatry. 46:1989;625-631.
37. Rose W.C., Haines W.J., Warner D.T. The amino acid requirements of man. J Biol Chem. 206:1954;421-430.
38. Schildkraut J.J. The catecholamine hypothesis of affective disorders A review of supporting evidence . Am J Psychiatry. 122:1965;509-522.
39. Siever L.J., Davis K.L. Overview Toward a dysregulation hypothesis of depression . Am J Psychiatry. 142:1985;1017-1031.
40. Shopsin B., Friedman E., Gershon S. Parachlorophenylaline reversal of tranylcypromine effects in depressed patients. Arch Gen Psychiatry. 33:1976;811-891.
41. Shopsin B., Gershon S., Goldstein M., Friedman E., Wilk S. Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients. Psychopharmacol Comm. 1:1975;239-249.
42. Smith S.E., Pihl R.O., Young S.W., Ervin F.R. A test of possible cognitive and environmental influences on the mood lowering effect of tryptophan depletion in normal males. Psychopharmacology. 91:1987;451-457.
43. Tricyclic antidepressants - blood level measurements and clinical outcome An APA Task Force report . Am J Psychiatry. 142:1985;155-162.
44. Williams WA, Hommer DW, Shoaf S, Goldman DS, Geyer C, Linnoila MI. Behavioral and biological effects of acute depletion of plasma tryptophan in patients with alcoholism and normal volunteers. Presented at the 150th Annual Meeting of the American Psychiatric Association, New Research Abstracts, NR #165, May 19, 1997.
45. Young S.N., Ervin F.R., Pihl R.O., Finn P. Biochemical aspects of tryptophan depletion in primates. Psychopharmacology. 98:1989;508-511.
46. Young V.R., Hussein M.A., Murray E., Scrimshaw N.S. Plasma tryptophan response curve and its relation to tryptophan requirements in young adult men. J Nutrition. 101:1971;45-60.
47. Young V.R., Hussein M.A., Murray E., Scrimshaw N.S. Tryptophan intake, spacing of meals, and diurnal fluctuations of plasma tryptophan in men. Am J Clin Nutrition. 22:1969;1563-1567.
48. Young S.N., Smith S.E., Pihl R., Ervin F.R. Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology. 87:1985;173-177.